A multicenter, randomized, active-controlled study to assess the safety, tolerability, and efficacy of FTY720 in patients with acute, non-infectious intermediate, posterior and pan uveitis.

Trial Profile

A multicenter, randomized, active-controlled study to assess the safety, tolerability, and efficacy of FTY720 in patients with acute, non-infectious intermediate, posterior and pan uveitis.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 25 Jan 2014

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Intermediate uveitis; Panuveitis; Posterior uveitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top